Additional file 1: Figure S1. of Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials

Funnel plot. Figure S2. Subgroup analysis of OS rate from available data. Figure S3. Subgroup analysis of ORR from available data. Figure S4. Comparison of OS rates between HMA vs. LDAC in AML patients. Table S1. Search detail in PubMed, EMBASE, and Cochrane database of systematic review. Table S2. Additional characteristics of randomized trials. Table S3. Risk of bias assessment of studies according to Cochrane risk bias assessment tool. Table S4. Characteristics of trials (ad hoc studies) comparing HMAs and LDAC in AML patients. (DOC 1145 kb

Additional file 10: of Purification of nanogram-range immunoprecipitated DNA in ChIP-seq application

Size distribution of sequencing reads from H3K4me3 ChIP-seq data. (PDF 203 kb

Le Courrier

17 novembre 18251825/11/17 (A0,N321)

Additional file 2: of Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues

Figures S1-S10 and Supplementary figure legends related to main text figures. (PPTX 6670 kb